Raymond James analyst Lawrence Keusch maintained a Buy rating on Teleflex (TFX) today and set a price target of $440.00. The company’s shares closed last Friday at $371.91.
According to TipRanks.com, Keusch is a 4-star analyst with an average return of 5.9% and a 63.4% success rate. Keusch covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Baxter International, and Intuitive Surgical.
Currently, the analyst consensus on Teleflex is a Strong Buy with an average price target of $416.22, an 8.6% upside from current levels. In a report released yesterday, Piper Sandler also maintained a Buy rating on the stock with a $420.00 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $405.07 and a one-year low of $221.27. Currently, Teleflex has an average volume of 247K.
Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of TFX in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Teleflex was founded in 1943 and is headquartered in Wayne, PA.
